If you like rollercoasters, you've probably loved the past month on the stock market. The Dow Jones Industrial Average (DJINDICES: ^DJI ) has climbed to a new peak, fallen off a cliff, gone round and round, and finished just about where it started.
^DJI data by YCharts.
Today the ride continued, with the Dow and S&P 500 (SNPINDEX: ^GSPC ) rising in early trading, dropping sharply around noon, and finally climbing back to small gains. As of 3:25 EDT the Dow has gained 0.18%, while the S&P 500 is up 0.43%.
Investors are already speculating about tomorrow's unemployment numbers from the Department of Labor. Economists expect 164,000 jobs to have been added in May, pegging the unemployment rate at 7.5% -- decent but not spectacular numbers.�
Despite the many negative headlines, Verizon (NYSE: VZ ) stock is leading the Dow today, climbing 3.4%. The Guardian broke a story about an NSA order requiring the company to turn over information about both international and domestic telephone calls. This may seem to reflect poorly on Verizon, but the company had little choice but to turn over information, and other telecom companies are likely doing the same. �
5 Best Blue Chip Stocks To Watch For 2015: OSI Systems Inc.(OSIS)
OSI Systems, Inc., together with its subsidiaries, designs and manufactures electronic systems and components for homeland security, healthcare, defense, and aerospace markets worldwide. The company operates in three divisions: Security, Healthcare, and Optoelectronics and Manufacturing. The Security division provides security and inspection systems under the Rapiscan Systems name. Its products include baggage and parcel inspection, cargo and vehicle inspection, hold baggage screening, and people screening products to search for weapons, explosives, drugs, and other contraband, as well as for the verification of cargo manifests for monitoring the export and import of controlled materials. This division also offers various turn-key security screening solutions under the S2 trade name. The Healthcare division provides patient monitoring, diagnostic cardiology, and anesthesia delivery and ventilation systems under the Spacelabs name that are used in critical care, emergency, and perioperative areas within hospitals, as well as physician?s offices, medical clinics, and ambulatory surgery centers. The Optoelectronics and Manufacturing division offers optoelectronic devices for the aerospace and defense, avionics, medical imaging and diagnostic, renewable energy, biochemistry analysis, pharmaceutical, nanotechnology, telecommunications, construction, and homeland security markets under the OSI Optoelectronics name; and electronics manufacturing services to original equipment manufacturers under the OSI Electronics name. This division also provides laser-based remote sensing devices to detect and classify vehicles in toll and traffic management systems under the OSI Laserscan name; blood pressure cuffs and unifusors under the Statcorp Medical name; and solid-state laser products for aerospace, defense, telecommunication, and medical applications under the OSI LaserDiode trade name. The company was founded in 1987 and is headquartered in Hawthorne, California.
Advisors' Opinion:- [By Bryan Murphy]
It's tragic that it takes an event like the one earlier this week at a Nevada middle school to put building security stocks in the spotlight. But, reality is reality. The death of one teacher as well as the student/shooter himself has once again underscored the need for names like View Systems Inc. (OTCBB:VSYM), OSI Systems, Inc. (NASDAQ:OSIS), and American Science & Engineering, Inc. (NASDAQ:ASEI). These three companies make equipment that may have prevented the shooting at the school. As is so often the case, interest in defense-oriented equipment - and a stronger likelihood of buying them - is eventually going to impact stocks like ASEI, OSIS, and VSYM for the better.
- [By John Udovich]
Small cap security and surveillance stocks OSI Systems, Inc (NASDAQ: OSIS), Vimicro International Corporation (NASDAQ: VIMC), Analogic Corporation (NASDAQ: ALOG), Lifelock Inc (NYSE: LOCK) and View Systems Inc (OTCBB: VSYM) have been producing a steady flow of news lately that investors might want to take a closer look at. After all, the whole security and surveillance industry is pretty vast as it would include everything from airport scanners to security cameras to software securing everyone�� personal or online data. With that in mind, here is a look at the latest news from important small cap security and surveillance stocks:
Hot International Stocks To Invest In Right Now: Clovis Oncology Inc (CLVS)
Clovis Oncology, Inc. (Clovis) incorporated on April 20, 2009, is a Development-stage Company. The Company is a Biopharmaceutical Company. The Company focuses on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets. The Company also focuses on the treatment of specific subsets of cancer populations. During the year ended December 31, 2010, the Company was in the process of developing three product candidates for which it holds global marketing rights: CO-101, a lipid-conjugated form of the anti-cancer drug gemcitabine; CO-1686, an oral epidermal growth factor receptor (EGFR) mutant-selective inhibitor and CO-338, a poly ADP (Adenosine Diphosphate)-ribose polymerase (PARP) inhibitor. Effective November 19, 2013, Clovis Oncology Inc acquired the entire share capital of Ethical Oncology Science SpA.
CO-101 - a Lipid-Conjugated Form of the Anti-Cancer Drug Gemcitabine
CO-101 is designed to treat patients with pancreatic cancer whose tumors express low amounts of a membrane transporter protein on the surface of the cancer cell known as hENT1 and are thus expected to be resistant to standard gemcitabine-based therapy. Based on the published results of multiple studies assessing the correlation of hENT1 expression to survival outcomes in pancreatic cancer patients treated with gemcitabine, the Company estimates that approximately 40% to 50% of pancreatic patients express low levels of hENT1, and thus derive little or no benefit from gemcitabine therapy. CO-101 is in an international, randomized and controlled 360-patient study for the first-line treatment of metastatic pancreatic cancer. This open-label study compares CO-101 to gemcitabine as a first-line therapy in patients with metastatic pancreatic cancer. Clovis is partnered with Ventana Medical Systems for the development and commercialization of a companion diagnostic for the assessment of hENT1 levels.
CO-1686-an Oral EGFR Mutant-Selective ! Inhibitor
CO-1686 is an orally available, small molecule covalent inhibitor of the cancer-causing mutant forms of EGFR for the treatment of non-small cell lung cancer (NSCLC). CO-1686 targets both the initial activating EGFR mutations as well as the primary resistance mutation, T790M, it treats both first- and second-line NSCLC patients with EGFR mutations. Such initiating activating mutations occur in approximately 10% to 15% of NSCLC cases in Caucasian patients and approximately 30% to 35% of NSCLC cases in East Asian patients. Following treatment with approved NSCLC therapies, Tarceva (erlotinib) or Iressa (gefitinib), both known as tyrosine kinase inhibitors (TKIs), approximately half of these patients develop the T790M mutation.
The Company focuses on the development of CO-1686 as both a second-line therapy for EGFR-mutated NSCLC patients who become resistant to TKIs due to the emergence of the T790M secondary mutation and as a first-line treatment for EGFR-mutated NSCLC. Clovis is partnered with Roche Molecular Systems for the development and commercialization of a companion diagnostic for identification of EGFR mutations.
CO-338-a PARP Inhibitor
CO-338 is a small molecule PARP inhibitor that the Company focuses to develop as both monotherapy and in combination with chemotherapeutic agents for the treatment of selected cancer patients. CO-338 is in a Phase I clinical trial to determine the maximum tolerated dose of oral CO-338 that can be combined with intravenous, or IV, platinum chemotherapy in the treatment of solid tumors. This program is supplemented by two ongoing investigator-initiated trials, using the IV formulation of CO-338: a Phase I/II study in germ-line BRCA mutant breast and ovarian cancer and a Phase II study in the adjuvant treatment of germ-line BRCA mutant and triple-negative breast cancer. The Company also focuses on initiating a Phase I monotherapy study of the oral formulation, to determine an appropriate dose and schedule.!
The Company competes with Eli Lilly, Teva Pharmaceutical Industries, APP Pharmaceuticals, AB Science SA, Amgen Inc., Astellas Pharma, BioSante Pharmaceuticals, Inc., Celgene Corporation, Immunomedics, Inc., Lorus Therapeutics, Threshold Pharmaceuticals, Inc., Boehringer Ingelheim, Pfizer, Sanofi-Aventis, Astra Zeneca, Abbott, Merck, Eisai, Cephalon and Biomarin.
Advisors' Opinion:- [By Sean Williams]
What: Shares of Clovis Oncology (NASDAQ: CLVS ) , a biopharmaceutical company that's developing anti-cancer therapies, vaulted higher by as much as 136% (that's not a typo!) after reporting positive data on two early stage experimental treatments -- CO-1686 in EGFR-mutant non-small cell lung cancer (NSCLC) and Rucaparib in a monotherapy study of solid tumors -- at the American Society of Clinical Oncology's annual meeting.
- [By Brian Orelli]
Plenty of data was presented at the American Society for Clinical Oncology meeting over the weekend, causing the first set of ASCO pops, but Clovis Oncology (NASDAQ: CLVS ) looks like the clear winner, more than doubling today as the company presented data on its two cancer drugs rucaparib and CO-1686.
- [By John Udovich]
On Wednesday, small cap cancer stock Clovis Oncology Inc (NASDAQ: CLVS) soared 16.68% after announcing a $200 million cancer deal plus the biotech has more than tripled since late 2011, meaning it might be time to take a closer look at what�� driving the stock higher as well as look at the performance of biotech ETF benchmarks like iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).
- [By Jake L'Ecuyer]
Clovis Oncology (NASDAQ: CLVS) was also up, gaining 7.26 percent to $79.35 after the company announced 2014 objectives and financial outlook. The company projected to initiate three global registration studies for CO-1686.
Hot International Stocks To Invest In Right Now: Ulta Salon Cosmetics and Fragrance Inc (ULTA)
Ulta Salon, Cosmetics & Fragrance, Inc. (Ulta), incorporated on January 9, 1990, is a beauty retailer, which provides one-stop shopping for prestige, mass and salon products and salon services in the United States. During the year ended January 28, 2012 (fiscal 2011), the Company opened 61 new stores. It operates full-service salons in all of its stores. Its Ulta store format includes an open and modern salon area with approximately eight to 10 stations. The entire salon area is approximately 950 square feet with a concierge desk, skin treatment room, semi-private shampoo and hair color processing areas. Each salon is a full-service salon offering hair cuts, hair coloring and permanent texture, with salons also providing facials and waxing.
The Company offers products in the categories, such as cosmetics, which includes products for the face, eyes, cheeks, lips and nails; haircare, which includes shampoos, conditioners, styling products, and hair accessories; salon styling tools, which includes hair dryers, curling irons and flat irons; skincare and bath and body, which includes products for the face, hands and body; fragrance for both men and women; private label, consisting of Ulta branded cosmetics, skincare, bath and body products and haircare, and other, including candles, home fragrance products and other miscellaneous health and beauty products. The Company has combined its three operating segments: retail stores, salon services and e-commerce, into one reportable segment.
The Company competes with Macy��, Nordstrom, Sephora, Bath & Body Works, CVS/pharmacy, Walgreens, Target, Wal-Mart, Regis Corp., Sally Beauty and JCPenney salons.
Advisors' Opinion:- [By Teresa Rivas]
Ulta Salon (ULTA) jumped more than 13% after its second quarter beat estimates and raised its full year comparable sales guidance.
Safeway (SWY) was up nearly 4% after an upgrade to Outperform at Credit Suisse, which also upgraded lululemon (LULU), sending shares up 1%, and downgraded Under Armour (UA)��hares were down 1.6%.
- [By Wallace Witkowski]
Shares of Ulta (ULTA) �rose 8.7% to $92.72 in heavy volume after the company reported first-quarter earnings of 77 cents a share on revenue of $713.8 million.
- [By Dan Caplinger]
Finally, beyond the Dow, the end of earnings season and M&A activity continued to move stocks. Ulta Salon (NASDAQ: ULTA ) has soared 15.6% after it released favorable results, including same-store sales gains of 6.7% and a 23% increase in overall revenue. Somewhat weak guidance for the current quarter wasn't enough to slow the stock's advance. Meanwhile, Cooper Tire (NYSE: CTB ) launched 40% higher after getting a $35 per-share buyout bid from Indian company Apollo Tyres. If companies see value even as the stock market pauses or corrects, then further acquisition activity could well spur the market's bull run onward.
- [By WWW.DAILYFINANCE.COM]
AlamyWebsites can help direct you to beauty-related freebies. Inner beauty matters most in my book, but trying to look your best outwardly can be important, too. Striving for beauty on the outside by using beauty products can help boost your confidence and show others that you take good care of yourself. On average, Americans spend more than $400 a year on personal care products. Although cosmetics and beauty products can add up to a pretty penny, beauty doesn't need to come with a hefty price tag. Here are some tips to manage beauty on a budget. 1. Free Samples Marketers love giving out free samples so consumers have the chance to try new products and fall in love with their products. The hope is that if you try a little, you'll like it enough to buy the full-size product at its full retail price. For frugal shoppers, free samples can be a tool that allows us the chance to stretch our dollars. By taking advantage of a variety of free beauty samples from many manufacturers, over time we can end up with enough free sample products to replace a few full-size ones. One woman who has perfected the search for freebies is Heather Hernandez, founder of Freebies4Mom.com. She started her site, which curates the best free samples available online, back in 2007. By signing up for her free e-mail newsletter you can be notified when new free samples are available and where to get them. Besides visiting Freebies4Mom.com, Heather shares two of her favorite sources for online freebies: SampleSource and PinchMe. SampleSource.com is a relatively new site that allows users to get free brand name samples. She recently received a free shampoo and new toothbrush from their site, which is free to join. PinchMe.com allows consumers to try free products in exchange for providing feedback on a short survey. On her last visit to the site, she got to select a free nail polish in the color of her choice. PinchMe has become very popular, so she recommends that you "pay attention to
Hot International Stocks To Invest In Right Now: Simpson Manufacturing Company Inc.(SSD)
Simpson Manufacturing Co., Inc., through its subsidiaries, engages in the design, engineering, manufacture, and sale of building products. It offers wood-to-wood, wood-to-concrete, and wood-to-masonry connectors; screw fastening systems and collated screws; stainless steel fasteners; pre-fabricated shear walls and moment-frames; truss plates; and a range of adhesives, chemicals, mechanical anchors, carbide drill bits, and powder-actuated tools for concrete, masonry, and steel markets, as well as a range of concrete repair products and engineered materials for the repair, strengthening, and restoration of asphalt and masonry construction. The company markets its products to the residential construction, light industrial and commercial construction, remodeling, and do-it-yourself markets primarily in the United States, Canada, Europe, Asia, and the South Pacific. Simpson Manufacturing Co., Inc. was founded in 1956 and is based in Pleasanton, California.
Advisors' Opinion:- [By mitu77]
In the recent past, we have observed that a customer�� appetite for data storage has been constantly increasing. The need for speed has been the prime constraint for the customer application with voluminous data existing in applications like data warehousing and data mining. Flash drives are being unanimously preferred by customers for their storage solutions and deploying the application in a cloud computing environment. Flash drives provided speed, which can be almost 3 times as compared to conventional storage disk devices. Declining price of the flash drive is again a constraint that has enabled flash drive or the Solid State Drives (SSD) to be a favorite choice for customers.
- [By Seth Jayson]
Margins matter. The more Simpson Manufacturing (NYSE: SSD ) keeps of each buck it earns in revenue, the more money it has to invest in growth, fund new strategic plans, or (gasp!) distribute to shareholders. Healthy margins often separate pretenders from the best stocks in the market. That's why we check up on margins at least once a quarter in this series. I'm looking for the absolute numbers, so I can compare them to current and potential competitors, and any trend that may tell me how strong Simpson Manufacturing's competitive position could be.
- [By jaggom]
However, the prices for NAND are expected to remain in the mid single-digits in the quarter, but the company has lowered its costs in the previous quarter that should help the company to keep the margin intact. The NAND business is witnessing good demand due to the booming market for solid-state drives (SSD) and mobile. Thus, a slight drop in pricing should be compensated for by higher volumes and lower costs.
- [By ICRAOnline]
Though currently at a very nascent stage, the HDD-maker�� hold in the solid state drive (SSD) is growing at a stable rate. During the quarter, SSD revenue was $113 million, forming around 3.1% of the total revenue. But the company is confident that the growth rate of its enterprise SSD will outpace the industry-wide enterprise SSD growth rate in the longer run.
Hot International Stocks To Invest In Right Now: TearLab Corporation(TEAR)
TearLab Corporation operates as an ophthalmic device company. It engages in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company?s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab disposable and the TearLab pen, as well as provides a quantitative reading for the operator. TearLab Corporation markets its system through a network of distributors in North America, Europe, and Asia. The company, formerly known as OccuLogix, Inc., was founded in 1996 and is headquart ered in San Diego, California.
Advisors' Opinion:- [By Seth Jayson]
TearLab (Nasdaq: TEAR ) reported earnings on May 13. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), TearLab beat expectations on revenues and exceeded expectations on earnings per share. - [By Roberto Pedone]
One potential earnings short-squeeze candidate is in-vitro diagnostic player TearLab (TEAR), which is set to release numbers on Tuesday after the market close. Wall Street analysts, on average, expect TearLab to report revenue of $3.51 million on a loss of 13 cents per share.
This company has managed to top Wall Street estimates two times over the last four quarters, which is a bullish earnings trend. If TearLab can delve another beat, then shares could be setting up for a large move higher.
The current short interest as a percentage of the float for TearLab is extremely high at 37.1%. That means that out of the 25.54 million shares in the tradable float, 8.59 million shares are sold short by the bears. This is a huge short interest on a stock with a very low tradable float. If the bulls get the earnings news they're looking for, then shares of TEAR could easily explode higher post-earnings as the bears jump to cover some of their bets.
From a technical perspective, TEAR is currently trending above both its 50-day and 200-day moving averages, which is bullish. This stock has been uptrending strong for the last six months, with shares moving higher from its low of $5.26 to its recent high of $15.18 a share. During that uptrend, shares of TEAR have been making mostly higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of TEAR within range of triggering a major breakout trade post-earnings.
If you're bullish on TEAR, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $14.28 to its 52-week high at $15.18 a share with high volume. Look for volume on that move that registers near or above its three-month average action of 942,598 shares. If that breakout hits, then TEAR will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside
No comments:
Post a Comment